These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28987475)

  • 1. Current perspectives on the role of CD8+ T cells in systemic sclerosis.
    Fuschiotti P
    Immunol Lett; 2018 Mar; 195():55-60. PubMed ID: 28987475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin-Resident Effector Memory CD8
    Li G; Larregina AT; Domsic RT; Stolz DB; Medsger TA; Lafyatis R; Fuschiotti P
    J Invest Dermatol; 2017 May; 137(5):1042-1050. PubMed ID: 28012718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.
    Fuschiotti P; Larregina AT; Ho J; Feghali-Bostwick C; Medsger TA
    Arthritis Rheum; 2013 Jan; 65(1):236-46. PubMed ID: 23001877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc).
    Klein M; Schmalzing M; Almanzar G; Benoit S; Hamm H; Tony HP; Goebeler M; Prelog M
    Autoimmunity; 2016 Dec; 49(8):532-546. PubMed ID: 27560622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CD226 Expression on CD8+ T Cells Is Associated with Upregulated Cytokine Production and Endothelial Cell Injury in Patients with Systemic Sclerosis.
    Ayano M; Tsukamoto H; Kohno K; Ueda N; Tanaka A; Mitoma H; Akahoshi M; Arinobu Y; Niiro H; Horiuchi T; Akashi K
    J Immunol; 2015 Aug; 195(3):892-900. PubMed ID: 26109642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
    Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
    Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
    Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 and interleukin-13 as possible therapeutic targets in systemic sclerosis.
    Gasparini G; Cozzani E; Parodi A
    Cytokine; 2020 Jan; 125():154799. PubMed ID: 31400638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of IL-13 in systemic sclerosis.
    Fuschiotti P
    Cytokine; 2011 Dec; 56(3):544-9. PubMed ID: 21920770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3z sequesters cytosolic T-bet, upregulating IL-13 levels in T
    Cascio S; Medsger TA; Hawse WF; Watkins SC; Milcarek C; Moreland LW; Lafyatis RA; Fuschiotti P
    J Allergy Clin Immunol; 2018 Jul; 142(1):109-119.e6. PubMed ID: 29155097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis.
    Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B
    Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA-3 up-regulation in CD8+ T cells as a biomarker of immune dysfunction in systemic sclerosis, resulting in excessive interleukin-13 production.
    Medsger TA; Ivanco DE; Kardava L; Morel PA; Lucas MR; Fuschiotti P
    Arthritis Rheum; 2011 Jun; 63(6):1738-47. PubMed ID: 21638273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis.
    Tsuji-Yamada J; Nakazawa M; Minami M; Sasaki T
    J Rheumatol; 2001 Jun; 28(6):1252-8. PubMed ID: 11409116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T cells in systemic sclerosis.
    Fuschiotti P
    Immunol Res; 2011 Aug; 50(2-3):188-94. PubMed ID: 21717073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.
    Hussein MR; Hassan HI; Hofny ER; Elkholy M; Fatehy NA; Abd Elmoniem AE; Ezz El-Din AM; Afifi OA; Rashed HG
    J Clin Pathol; 2005 Feb; 58(2):178-84. PubMed ID: 15677539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response.
    Masui Y; Asano Y; Shibata S; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
    Rheumatology (Oxford); 2013 Jul; 52(7):1239-44. PubMed ID: 23443327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis.
    Clark KE; Lopez H; Abdi BA; Guerra SG; Shiwen X; Khan K; Etomi O; Martin GR; Abraham DJ; Denton CP; Stratton RJ
    Arthritis Res Ther; 2015 Mar; 17(1):73. PubMed ID: 25885360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.